LEDAGA

This brand name is authorized in Austria, Estonia, Finland, France, Croatia, Ireland, Israel, Italy, Lithuania, Netherlands, Poland, United Kingdom

Active ingredients

The drug LEDAGA contains one active pharmaceutical ingredient (API):

1 Chlormethine UNII L0MR697HHI - MECHLORETHAMINE HYDROCHLORIDE

Chlormethine is a bifunctional alkylating agent that inhibits rapidly proliferating cells. It works by binding to DNA, crosslinking two strands and preventing cell duplication. It binds to the N7 nitrogen on the DNA base guanine. It has been derivatized into the estrogen analogue estramustine phosphate, used to treat prostate cancer. Read about Chlormethine

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
LEDAGA Gel	European Medicines Agency (EU)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
L01AA05	Chlormethine	L Antineoplastic and immunomodulating agents → L01 Antineoplastic agents → L01A Alkylating agents → L01AA Nitrogen mustard analogues
Discover more medicines within L01AA05

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: EE	Ravimiamet	Identifier(s): 1739752
Country: FI	Lääkealan turvallisuus- ja kehittämiskeskus	Identifier(s): 466667
Country: FR	Base de données publique des médicaments	Identifier(s): 64465866
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 372875
Country: IL	מִשְׂרַד הַבְּרִיאוּת	Identifier(s): 7823
Country: IT	Agenzia del Farmaco	Identifier(s): 045315013
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1082467
Country: NL	Z-Index G-Standaard, PRK	Identifier(s): 148490
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100387912